KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.265 $5.95 Friday, 26th Apr 2024 WINT stock ended at $5.23. This is 3.15% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.89% from a day low at $5.06 to a day high of $5.51.
90 days $0.265 $5.95
52 weeks $0.265 $5.95

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Jan 11, 2022 $1.46 $1.53 $1.40 $1.49 174 323
Jan 10, 2022 $1.39 $1.44 $1.37 $1.40 55 721
Jan 07, 2022 $1.40 $1.42 $1.37 $1.38 38 994
Jan 06, 2022 $1.44 $1.47 $1.36 $1.42 152 629
Jan 05, 2022 $1.53 $1.56 $1.41 $1.42 96 874
Jan 04, 2022 $1.61 $1.61 $1.52 $1.55 109 329
Jan 03, 2022 $1.59 $1.63 $1.50 $1.60 197 314
Dec 31, 2021 $1.42 $1.72 $1.40 $1.61 832 370
Dec 30, 2021 $1.43 $1.49 $1.39 $1.42 275 829
Dec 29, 2021 $1.45 $1.48 $1.38 $1.40 248 627
Dec 28, 2021 $1.50 $1.50 $1.45 $1.45 220 638
Dec 27, 2021 $1.58 $1.58 $1.48 $1.49 248 716
Dec 23, 2021 $1.53 $1.58 $1.52 $1.58 89 179
Dec 22, 2021 $1.55 $1.60 $1.53 $1.53 158 154
Dec 21, 2021 $1.59 $1.62 $1.54 $1.55 129 677
Dec 20, 2021 $1.58 $1.63 $1.55 $1.59 100 201
Dec 17, 2021 $1.53 $1.65 $1.47 $1.63 115 875
Dec 16, 2021 $1.60 $1.63 $1.52 $1.56 114 297
Dec 15, 2021 $1.56 $1.60 $1.42 $1.58 233 759
Dec 14, 2021 $1.58 $1.63 $1.49 $1.51 109 605
Dec 13, 2021 $1.61 $1.65 $1.52 $1.59 66 445
Dec 10, 2021 $1.60 $1.67 $1.57 $1.63 82 655
Dec 09, 2021 $1.67 $1.67 $1.61 $1.61 74 065
Dec 08, 2021 $1.58 $1.67 $1.58 $1.66 66 102
Dec 07, 2021 $1.48 $1.62 $1.48 $1.59 147 206
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT